Selective modulation of P-glycoprotein-mediated drug resistance

British Journal of Cancer

Volumn 85, Issue 12, 2001, Pages 1998-2003

  Bebawy, M ^a   Morris, M B ^a   Roufogalis, B D ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Chlorpromazine; Colchicine; Fluorescein colchicine; Multidrug resistance; P glycoprotein; Vinblastine

Indexed keywords

CHLORPROMAZINE; COLCHICINE; FLUORESCEIN; GLYCOPROTEIN P; PHOSPHOLIPID; VERAPAMIL; VINBLASTINE;

ALLOSTERISM; ARTICLE; BILAYER MEMBRANE; CANCER; CELL MEMBRANE; CELL VACUOLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG UPTAKE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN INTERACTION; TEMPERATURE DEPENDENCE;

EID: 0035556276     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2001.2184     Document Type: Article

References (23)

1. Co-operative, competitive and non-competitive interactions between modulators of P-glycoprotein
2. A continuous fluorescence assay for the study of P-glycoprotein-mediated drug efflux using inside-out membrane vesicles
3. Altered surface membrane glycoproteins in Vinca alkaloid-resistant human leukemic lymphoblasts
4. Increased accumulation of drugs in a multidrug resistant cell line by alteration of membrane biophysical properties
5. Continous culture of human lymphoblasts from peripheral blood of a child with acute leukaemia
6. Experimental reversal of P-glycoprotein-mediated multidrug resistance by pharmacological chemosensitisers
7. + pump in erythrocytes
8. Basic concepts of pharmacokinetic/pharmacodynamic (PK/PD) modelling
9. Membrane fluidization by ether, other anesthetics, and certain agents abolishes P-glycoprotein ATPase activity and modulates efflux from multidrug-resistant cells
10. The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter
11. Expression of human P-glycoprotein in yeast cells - Effects of membrane component sterols on the activity of P-glycoprotein
12. Specific drug binding by purified lipid-reconstituted P-glycoprotein: Dependence on the lipid composition
13. The P-glycoprotein multidrug transporter: Interactions with membrane lipids, and their modulation of activity
14. Equilibrium and kinetic effects of drugs on the shapes of human erythrocytes
15. Modulation of P-glycoprotein-mediated drug transport by alterations in lipid fluidity of rat liver canalicular membrane vesicles
16. Markedly altered membrane transport and intracellular binding of vincristine in multidrug-resistant Chinese hamster cells selected for resistance to vinca alkaloids
17. Kinetics of the multidrug transporter (P-glycoprotein) and its reversal
18. Chlorpromazine transport in membrane vesicles from multidrug resistant CCRF-CEM cells
19. Reversal of vinblastine transport by chlorpromazine in membrane vesicles from multidrug-resistant human CCRF-CEM leukaemia cells
20. Electrophoretic detection of reversible chlorpromazine. HCl binding at the human erythrocyte surface
21. The role of drug-lipid interactions in the biological activity of modulators of multi-drug resistance
22. Biphasic nature of the binding of cationic amphipaths with artificial and biological membranes
23. Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells